Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-25 @ 1:27 AM
NCT ID:
NCT06355193
Eligibility Criteria:
Inclusion Criteria:
* the diagnosis of SARS-Cov-2 infection confirmed by quantitative polymerase chain reaction (qPCR) test
* aged 18 years or older
* patients received more than 2 doses of SARS-Cov-2 vaccine
* asymptomatic or mild at the time of hospitalization
Exclusion Criteria:
* patients with malignant diseases, autoimmune diseases, liver and kidney diseases, blood diseases, neurological diseases, endocrine diseases and other serious diseases may affect the patient's participation in the trial or affect the results of the study
* pregnant women, lactating mothers; allergic conditions
* allergic to the known components of the drug
* patients vaccinated with vaccines less than 1 shot
* Patient does not agree to participate in this study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06355193
Study Brief:
Protocol Section:
NCT06355193